Have you experienced any rare neurological symptoms with famciclovir?

I don’t have personal experiences, but there are documented reports of rare neurological side‑effects with famciclovir. They are uncommon, but they’re recognized in the literature and in the drug’s labeling. Here’s a concise overview:

| Symptom | Frequency / Source | Typical Onset | Management / Notes |
|--------|--------------------|--------------|--------------------|
| Headache | Common adverse event (≈2–5 %); rarely severe. | Usually within first 1–2 days of therapy. | Over‑the‑counter analgesics; if persistent, review dose or switch therapy. |
| Dizziness / Light‑headedness | Reported in <1 % of patients in post‑marketing surveillance. | Often early in treatment. | Rest, monitor for falls; consider dose adjustment if severe. |
| Confusion / Cognitive changes | Very rare (case reports in post‑marketing data). | Variable; may appear after several doses. | Evaluate for other causes (renal impairment, drug interactions). |
| Ataxia / gait disturbances | Extremely rare (single‑case reports). | Typically after a few days of therapy. | Stop medication, monitor recovery; neurological exam may be warranted. |
| Seizures | Isolated reports; no clear causal link. | Usually in patients with pre‑existing epilepsy or renal dysfunction. | Discontinue famciclovir if seizure occurs; consult neurology. |
| Peripheral neuropathy | Sparse case reports. | May develop after prolonged use. | Consider drug cessation; neuropathic pain therapy if needed. |

Why do these happen?

• Renal clearance: Famciclovir is eliminated largely by the kidneys. Impaired renal function can lead to drug accumulation and higher central nervous system exposure.
  
• Drug interactions: Concomitant use of other CNS‑active agents (e.g., benzodiazepines, opioids) may amplify neuro‑toxicity.
  
• Individual susceptibility: Genetics or underlying neurological disease can predispose some patients.
  
  

What to do if you notice neurological symptoms?

1. Stop the medication (or have your clinician stop it) until symptoms resolve.
   
2. Seek medical evaluation: A neurologist or primary care provider can assess for alternative causes and decide whether to rechallenge with famciclovir at a lower dose or switch to another antiviral (e.g., valacyclovir, acyclovir).
   
3. Report the event: In the U.S., report to the FDA’s MedWatch; in other countries, similar pharmacovigilance systems exist.
   
   

Bottom line

Rare neurological events with famciclovir are documented but infrequent. Most patients tolerate the drug well. If you or someone you know experiences headaches, dizziness, confusion, ataxia, seizures, or neuropathic pain while on famciclovir, contact a healthcare professional promptly. They can determine whether the medication should be stopped, dose‑reduced, or swapped for an alternative.